Radiolabeling approaches of nanoparticles with 99mTc

Contrast Media and Molecular Imaging

Volumn 8, Issue 4, 2013, Pages 333-339

  Psimadas, Dimitrios ^a,b,c   Bouziotis, Penelope ^b   Georgoulias, Panagiotis ^a   Valotassiou, Varvara ^a   Tsotakos, Theodoros ^b,c   Loudos, George ^c  

^a UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^b Biomolecular Physics Laboratory   (Greece)

^c UNIVERSITY OF WEST ATTICA   (Greece)

Author keywords

Biodistribution; Imaging; Nanomedicine; Nanoparticles; Radiolabeling; Technetium

Indexed keywords

CARBOXYLIC ACID; CHELATING AGENT; DEXTRAN; DOXORUBICIN; GALLIUM 68; GASTRIN RELEASING PEPTIDE; HYDROXYL GROUP; INDIUM 111; LIPOSOME; MERCAPTO ACETYL TRIGLYCINE; MORPHOLINO OLIGONUCLEOTIDE; PENTETIC ACID; POLY(ISOBUTYL 2 CYANOACRYLATE); POLYGLYCOLIC ACID; SILVER NANOPARTICLE; SODIUM BOROHYDRIDE; TECHNETIUM 99M; TRIPALMITIN; UNCLASSIFIED DRUG;

DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG STABILITY; GEL PERMEATION CHROMATOGRAPHY; HIGH TEMPERATURE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; NANOENCAPSULATION; NANOMEDICINE; NONHUMAN; NUCLEAR MEDICINE; OXIDATION; PARTICLE SIZE; PATIENT SAFETY; PH; PHOTON EMISSION TOMOGRAPHY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RADIOCHEMISTRY; REVIEW;

HUMANS; NANOMEDICINE; NANOPARTICLES; RADIOISOTOPES; TECHNETIUM;

EID: 84876833262     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.1530     Document Type: Review

References (47)

1. Imam SK. Molecular nuclear imaging: the radiopharmaceuticals. Cancer Biother Radiopharm 2005; 20: 163-172.
2. Schladt TD, Schneider K, Schild H, Tremel W. Synthesis and bio-functionalization of magnetic nanoparticles for medical diagnosis and treatment. Dalton Trans 2011; 40: 6315-6343.
3. Islam T, Harisinghani MG. Overview of nanoparticle use in cancer imaging. Cancer Biomark 2009; 5: 61-67.
4. Snehalatha M, Venugopal K, Saha RN, Babbar AK, Sharm RK. Etoposide loaded PLGA and PCL nanoparticles II: biodistribution and pharmacokinetics after radiolabeling with Tc-99m. Drug Deliv 2008; 15: 277-287.
5. Boerman OC, Laverman P, Oyen WJG, Corstens FHM, Storm G. Radiolabeled liposomes for scintigraphic imaging. Progr Lipid Res 2000; 39: 461-475.
6. Choi HS, Frangioni JV. Nanoparticles for biomedical imaging: fundamentals of clinical translation. Mol Imag 2010; 9: 291-310.
7. Hong H, Zhang Y, Sun J, Cai W. Molecular imaging and therapy of cancer with radiolabeled nanoparticles. Nano Today 2009; 4: 399-413.
8. Ting G, Chang CH, Wang HE, Lee TW. Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy. J Biomed Biotechnol 2010; pii: 953537.
9. Arulsudar N, Subramanian N, Mishra P, Sharma RK, Murthy RS. Preparation, characterisation and biodistribution of 99mTc-labeled liposome encapsulated cyclosporine. J Drug Target 2003; 11: 187-196.
10. Hamoudeh M, Kamleh MA, Diab R, Fessi H. Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer. Adv Drug Deliv Rev 2008; 60: 1329-1346.
11. Liu Z, Peng R. Inorganic nanomaterials for tumor angiogenesis imaging. Eur J Nucl Med Mol Imag 2010; 37(suppl 1): S147-S163.
12. Loudos G, Kagadis GC, Psimadas D. Current status and future perspectives of in vivo small animal imaging using radiolabeled nanoparticles. Eur J Radiol 2011; 78: 287-295.
13. Coleman RE. Radionuclide imaging in cancer medicine. In Holland-Frei Cancer Medicine, 6th edn, Kufe DW, Pollock RE, Weichselbaum RR, Bast RC, Gansler TS, Holland JF, Frei E (eds). American Cancer Society/BC Decker: Hamilton, Ontario, 2003; chapter 36h.
14. Banerjee S, Pillai MR, Ramamoorthy N. Evolution of Tc-99m in diagnostic radiopharmaceuticals. Semin Nucl Med 2001; 31: 260-277.
15. Fu CM, Wang YF, Chao YC, Hung SH, Yang MD. Directly labeling ferrite nanoparticles with Tc-99m radioisotope for diagnostic applications. IEEE Trans Magnet 2005; 40: 3003-3005.
16. Reddy LH, Sharma RK, Chuttani K, Mishra AK, Murthy RR. Etoposide-incorporated tripalmitin nanoparticles with different surface charge: formulation, characterization, radiolabeling, and biodistribution studies. AAPS J 2004; 7: e23.
17. Reddy LH, Sharma RK, Murthy RS. Enhanced tumour uptake of doxorubicin loaded poly(butyl cyanoacrylate) nanoparticles in mice bearing Dalton's lymphoma tumour. J Drug Target 2004; 12: 443-451.
18. Psimadas D, Baldi G, Ravagli C, Bouziotis P, Xanthopoulos S, Franchini MC, Georgoulias P, Loudos G. Preliminary evaluation of a 99mTc labeled hybrid nanoparticle bearing a cobalt ferrite core: in vivo biodistribution. J Biomed Nanotechnol 2012; 8: 575-585.
19. Mondal N, Halder KK, Kamila MM, Debnath MC, Pal TK, Ghosal SK, Sarkar BR, Ganguly S. Preparation, characterization, and biodistribution of letrozole loaded PLGA nanoparticles in Ehrlich Ascites tumor bearing mice. Int J Pharm 2010; 397: 194-200.
20. Subramanian S, Dandekar P, Jain R, Pandey U, Samuel G, Hassan PA, Patravale V, Venkatesh M. Technetium-99m-labeled poly(dl-lactide-co-glycolide) nanoparticles as an alternative for sentinel lymph node imaging. Cancer Biother Radiopharm 2010; 25: 637-644.
21. Halder KK, Mandal B, Debnath MC, Bera H, Ghosh LK, Gupta BK. Chloramphenicol-incorporated poly lactide-co-glycolide (PLGA) nanoparticles: formulation, characterization, technetium-99m labeling and biodistribution studies. J Drug Target 2008; 16: 311-320.
22. Banerjee T, Singh AK, Sharma RK, Maitra AN. Labeling efficiency and biodistribution of Technetium-99m labeled nanoparticles: interference by colloidal tin oxide particles. Int J Pharm 2005; 289: 189-195.
23. Wang AY, Kuo CL, Lin JL, Fu CM, Wang YF. Study of magnetic ferrite nanoparticles labeled with 99mTc-pertechnetate. J Radioanal Nucl Chem 2010; 284: 405-413.
24. Stevanović M, Maksin T, Petković J, Filipic M, Uskoković D. An innovative, quick and convenient labeling method for the investigation of pharmacological behavior and the metabolism of poly(dl-lactide-co-glycolide) nanospheres. Nanotechnology 2009; 20: 335102-12pp.
25. Richardson VJ, Jeyasingh K, Jewkes RF, Ryman BE, Tattersall MH. Properties of [99mTc] technetium-labelled liposomes in normal and tumour-bearing rats. Biochem Soc Trans 1977; 5: 290-291.
26. Theobald AE. Theory and practice. In Textbook of Radiopharmacy, Sampson CB (ed.). Gordon and Breach: New York, 1990; 127-129.
27. 3-dendrimer-FITC for cancer imaging. Bioorg Med Chem Lett 2011; 21: 5598-5601.
28. Faintuch BL, Núñez GE, Teodoro R, Moro AM, Mengatti J. Radiolabeled nano-peptides show specificity for an animal model of human PC3 prostate cancer cells. Clinics 2011; 66: 327-336.
29. Mendoza-Sánchez AN, Ferro-Flores G, Ocampo-García BE, Morales-Avila E, Ramirez Fde M, De León-Rodríguez LM, Santos-Cuevas CL, Medina LA, Rojas-Calderon EL, Camacho-Lopez MA. Lys3-bombesin conjugated to 99mTc-labelled gold nanoparticles for in vivo gastrin releasing peptide-receptor imaging. J Biomed Nanotechnol 2010; 6: 375-384.
30. Ocampo-García BE, Ramirez Fde M, Ferro-Flores G, De León-Rodríguez LM, Santos-Cuevas CL, Morales-Avila E, de Murphy A, Pedraza-Lopez M, Medina LA, Camacho-Lopez MA. (99m)Tc-labelled gold nanoparticles capped with HYNIC-peptide/mannose for sentinel lymph node detection. Nucl Med Biol 2011; 38: 1-11.
31. Morales-Avila E, Ferro-Flores G, Ocampo-García BE, De León-Rodríguez LM, Santos-Cuevas CL, García-Becerra R, Medina LA, Gomez-Olivan L. Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor α(v)β(3) expression. Bioconjug Chem 2011; 22: 913-922.
32. Ocampo-García B, Ferro-Flores G, Morales-Avila E, Ramírez Fde M. Kit for preparation of multimeric receptor-specific 99mTc-radiopharmaceuticals based on gold nanoparticles. Nucl Med Commun 2011; 32: 1095-1104.
33. Zhang Y, Sun Y, Xu X, Zhu H, Huang L, Zhang X, Zhang X, Qi Y, Shen Y-M. Radiosynthesis and micro-SPECT imaging of 99mTc-dendrimer poly(amido)-amine folic acid conjugate. Bioorg Med Chem Lett 2010; 20: 927-931.
34. Zhang Y, Sun Y, Xu X, Zhang X, Zhu H, Huang L, Qi Y, Shen Y-M. Synthesis, biodistribution, and microsingle photon emission computed tomography (SPECT) imaging study of technetium-99m labeled PEGylated dendrimer poly(amidoamine) (PAMAM)-folic acid conjugates. J Med Chem 2010; 53: 3262-3272.
35. Helbok A, Decristoforo C, Dobrozemsky G, Rangger C, Diederen E, Stark B, Prassl R, von Guggenberg E. Radiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: a comparison using different radiometals. J Liposome Res 2010; 20: 219-227.
36. Parrott MC, Benhabbour SR, Saab C, Lemon JA, Parker S, Valliant JF, Adronov A. Synthesis, radiolabeling, and bio-imaging of high-generation polyester dendrimers. J Am Chem Soc 2009; 131: 2906-2916.
37. Torres Martin de Rosales R, Tavaré R, Glaria A, Varma G, Protti A, Blower PJ. (99m)Tc-bisphosphonate-iron oxide nanoparticle conjugates for dual-modality biomedical imaging. Bioconjug Chem 2011; 22: 455-465.
38. Pereira MA, Mosqueira VC, Carmo VA, Ferrari CS, Reis EC, Ramaldes GA, Cardoso VN. Biodistribution study and identification of inflammatory sites using nanocapsules labeled with (99m)Tc-HMPAO. Nucl Med Commun 2009; 9: 749-755.
39. Phillips WT, Rudolph AS, Goins B, Klipper R. Biodistribution studies of liposome encapsulated hemoglobin (LEH) studied with a newly developed 99m-technetium liposome label. Biomater Artif Cells Immobilization Biotechnol 1992; 20: 757-760.
40. Bao A, Goins B, Klipper R, Negrete G, Mahindaratne M, Phillips WT. A novel liposome radiolabeling method using 99mTc-'SNS/S' complexes: in vitro and in vivo evaluation. J Pharm Sci 2003; 92: 1893-1904.
41. Bao A, Goins B, Klipper R, Negrete G, Phillips WT. Direct 99mTc labeling of pegylated liposomal doxorubicin (Doxil) for pharmacokinetic and non-invasive imaging studies. J Pharmacol Exp Ther 2004; 308: 419-425.
42. Kim J, Chung KH, Lee CM, Seo YS, Song HC, Lee KY. Lymphatic delivery of 99mTc-labeled dextran acetate particles including cyclosporine A. J Microbiol Biotechnol 2008; 18: 1599-1605.
43. Vera DR, Wallace AM, Hoh CK. [(99m)Tc]MAG(3)-mannosyl-dextran: a receptor-binding radiopharmaceutical for sentinel node detection. Nucl Med Biol 2001; 28: 493-498.
44. Vera DR, Wallace AM, Hoh CK, Mattrey RF. A synthetic macromolecule for sentinel node detection: (99m)Tc-DTPA-mannosyl-dextran. J Nucl Med 2001; 42: 951-959.
45. Matsunaga K, Hara K, Imamura T, Fujioka T, Takata J, Karube Y. Technetium labeling of dextran incorporating cysteamine as a ligand. Nucl Med Biol 2005; 32: 279-285.
46. Núñez EG, Faintuch BL, Teodoro R, Wiecek DP, da Silva NG, Papadopoulos M, Pelecanou M, Pirmettis G, de Oliveira Filho RS, Duatti A, Pasqualini R. Parameters optimization defined by statistical analysis for cysteine-dextran radiolabeling with technetium tricarbonyl core. Appl Radiat Isot 2011; 69: 663-669.
47. Pirmettis I, Arano Y, Tsotakos T, Okada K, Yamaguchi A, Uehara T, Morais M, Correia JD, Santos I, Martins M, Pereira S, Triantis C, Kyprianidou P, Pelecanou M, Papadopoulos M. New 99mTc(CO)3 mannosylated dextran bearing S-derivatized cysteine chelator for sentinel lymph node detection. Mol Pharm 2012; doi: 10.1021/mp300015s.